Topic: Biology

Researchers at the University of California San Diego have identified an enzyme called N4BP2 that causes a dramatic genetic event in cancer cells. This event, called chromothripsis, allows cancer cells to evolve quickly and develop resistance to treatment.

Cancer is a major health concern worldwide. One way it can become resistant to treatment is by rapidly evolving its DNA. Scientists have discovered the key to this rapid evolution: an enzyme called N4BP2. This enzyme causes a genetic event called chromothripsis, which breaks chromosomes into many fragments and reassembles them in the wrong order.

Chromothripsis was first recognized over 10 years ago as a major force in cancer progression. However, researchers had not known what caused it until now. The new findings, published in Science, point to potential new strategies for treating some of the most aggressive cancers.

Cancer cells use several tactics to survive therapy, but chromothripsis stands out because of its sheer scale. Rather than building up mutations gradually over time, this process can create dozens or even hundreds of genetic alterations in a single catastrophic episode.

The researchers used an imaging-based screening approach to systematically examine all known and predicted human nucleases. They monitored how each enzyme behaved in living cancer cells. One enzyme, N4BP2, stood out. It was uniquely able to enter micronuclei and fragment the DNA inside.

The team then tested whether N4BP2 directly causes chromothripsis. When they removed the enzyme from brain cancer cells, chromosome shattering dropped dramatically. In contrast, when they forced N4BP2 into the cell nucleus, intact chromosomes broke apart, even in otherwise healthy cells.

The researchers also examined more than 10,000 cancer genomes spanning multiple tumor types. Cancers with higher levels of N4BP2 activity showed significantly more chromothripsis and large-scale structural rearrangements. These tumors also had increased amounts of extrachromosomal DNA (ecDNA), circular DNA fragments that often carry cancer-promoting genes and are closely associated with aggressive growth and resistance to therapy.

Why It Matters

This discovery is important because it could lead to new strategies for treating some of the most aggressive cancers. Cancer cells' ability to rapidly evolve and develop resistance to treatment is a major challenge in cancer treatment. By understanding how this process works, scientists can develop more effective treatments.

Key Facts

• Scientists at the University of California San Diego have identified an enzyme called N4BP2 that causes chromothripsis in cancer cells.
• Chromothripsis is a dramatic genetic event that breaks chromosomes into many fragments and reassembles them in the wrong order.
• This process allows cancer cells to evolve quickly and develop resistance to treatment.
• The researchers used an imaging-based screening approach to identify N4BP2 as the enzyme responsible for chromothripsis.
• Cancers with higher levels of N4BP2 activity showed significantly more chromothripsis and large-scale structural rearrangements.

Key Terms

Chromothripsis

A dramatic genetic event that breaks chromosomes into many fragments and reassembles them in the wrong order.

Implications

This discovery is important because it could lead to new strategies for treating some of the most aggressive cancers. Cancer cells' ability to rapidly evolve and develop resistance to treatment is a major challenge in cancer treatment. By understanding how this process works, scientists can develop more effective treatments.